Ponticelli, C

Basiliximab significantly reduces acute rejection in renal transplant patients given triple therapy with azathioprine. [electronic resource] - Transplantation proceedings - 1009-10 p. digital

Publication Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial

0041-1345

10.1016/s0041-1345(00)02307-1 doi


Acute Disease
Adolescent
Adult
Aged
Anti-Inflammatory Agents--therapeutic use
Antibodies, Monoclonal--therapeutic use
Azathioprine--therapeutic use
Basiliximab
Cyclosporine--therapeutic use
Drug Therapy, Combination
Female
Graft Rejection
Humans
Immunosuppressive Agents--therapeutic use
Infections--etiology
Kidney Transplantation--immunology
Male
Middle Aged
Postoperative Complications--etiology
Prednisone--therapeutic use
Recombinant Fusion Proteins